An IV infusion is a route of administration, not a prescription category in its own right. The question of who can prescribe infusions in the UK therefore depends on what is being administered, why it is clinically indicated, and whether the practitioner has the appropriate professional authority, competence and governance arrangements.
For patients, this matters because a well-run IV service should make medical oversight visible rather than treating it as a behind-the-scenes detail. For clinics, it is a fundamental part of safe practice: the person assessing a patient, the person prescribing, and the person administering an infusion may be different professionals, but each must have a clearly defined and lawful role.
Who can prescribe infusions in the UK?
In the UK, prescribing is restricted to appropriately qualified and professionally regulated healthcare professionals. A doctor on the General Medical Council register may prescribe within their competence. Dentists may prescribe medicines relevant to dental practice, while other professions can prescribe only where they hold the required prescribing qualification or annotation and act within their recognised scope of practice.
In an IV setting, the most commonly relevant prescribers are doctors, nurse independent prescribers and pharmacist independent prescribers. Nurse and pharmacist prescribers must be registered with the Nursing and Midwifery Council or General Pharmaceutical Council respectively, and their prescribing status must be current. Registration alone does not confer prescribing rights: a nurse or pharmacist must have completed an approved prescribing programme and have the relevant annotation on their professional register.
Some other registered professionals, including certain physiotherapists, therapeutic radiographers, podiatrists and optometrists, may also qualify as independent or supplementary prescribers. Their prescribing authority is closely linked to their professional scope and clinical competence. Whether that extends to a particular infusion will depend on the medicine, the clinical indication, their training and their employer or clinic governance.
The practical question is not simply whether someone has a prescribing qualification. It is whether they are competent to assess the individual patient, make a diagnosis or clinical decision where required, consider contraindications and interactions, prescribe the selected product, and arrange appropriate monitoring.
A prescription is not the same as administration
A registered nurse, paramedic or other appropriately trained clinician may be able to administer an IV infusion without being the prescriber. Administration must, however, be supported by a valid legal mechanism and undertaken within the practitioner’s competence.
In many cases, an infusion is administered against a patient-specific direction, often shortened to PSD. This is a written instruction from an authorised prescriber for named individual patient care. The prescriber should have assessed the patient and determined that the treatment is appropriate before the product is supplied or administered.
This distinction is especially relevant in private IV services. A clinic should be able to explain who performed the assessment, who prescribed the treatment, and who will administer it. It should also document the product, dose, route, infusion rate, batch details where relevant, consent and any observations made during treatment.
Delegation does not remove accountability. The prescriber remains accountable for the prescribing decision, while the clinician administering the infusion is accountable for checking that the direction is valid, the product and dose are correct, the patient remains suitable on the day, and administration is performed safely.
When can a PGD be used for an infusion?
A patient group direction, or PGD, is a written instruction that allows specified registered health professionals to supply or administer a named medicine to groups of patients who meet defined criteria, without an individual prescription.
PGDs can be appropriate in limited, carefully governed circumstances. They are not a shortcut for individual clinical assessment, and they are not appropriate for every medicine, route or patient group. The direction must be authorised, clinically appropriate for the service, regularly reviewed and used only by professionals named and authorised to work under it.
For IV therapy, a PGD may be more difficult to justify than for a standardised service with a well-defined patient population. Infusions often require individual consideration of medical history, concurrent medicines, blood results where clinically indicated, renal function, cardiovascular status, allergy history and the reason for treatment. A patient-specific prescription is commonly the more suitable approach where treatment requires meaningful clinical judgement.
A PGD also does not turn a non-prescriber into a prescriber. It authorises supply or administration within tightly defined parameters. If the patient falls outside those parameters, has a new symptom, develops an adverse reaction or requires a change in treatment, escalation to an appropriate prescriber is required.
The product being infused changes the answer
Not all IV products carry the same legal and clinical considerations. Prescription-only medicines require a valid prescription or another lawful supply and administration mechanism, such as an appropriate PGD. This may include medicines used for hydration, antiemetic treatment, nutrient replacement or other clinical indications.
Some products may be available in other legal classifications, but that does not eliminate the need for safe clinical governance. The IV route has its own risks, including infection, extravasation, phlebitis, fluid overload, electrolyte disturbance and allergic or infusion reactions. A product’s availability does not establish that it is suitable for intravenous administration in a particular person.
Clinics should also be cautious about assuming that a product marketed for wellness purposes can be prescribed or administered without the same level of clinical scrutiny. The intended use, formulation, route, evidence base, product licence or specification, and patient-specific risk factors all matter. Where a medicine is used outside the terms of its licence, the prescriber needs a clear clinical rationale and must meet the professional standards that apply to that decision.
What good prescribing practice looks like
Safe prescribing for an infusion begins before a cannula is inserted. The clinician should obtain an appropriate history, review relevant conditions and medicines, assess allergies and establish the patient’s goals and expectations. The depth of assessment should reflect the proposed treatment and the individual’s risk profile rather than following a one-size-fits-all questionnaire.
The prescriber must be satisfied that there is a reasonable clinical basis for treatment. For some symptoms, such as persistent fatigue, recurrent headaches, unexplained nausea or reduced exercise tolerance, IV therapy may not be the right first step. These symptoms can have causes that need assessment through primary care or another appropriate clinical pathway. A responsible prescriber will recognise when investigation, referral or no treatment is the safer choice.
Consent should be informed and documented. Patients should understand the expected purpose of the infusion, realistic limitations of the evidence, material risks, alternatives and the plan if they experience an adverse effect. Consent is an ongoing process, not a signature obtained before treatment begins.
The administration environment matters too. The team should have suitable training in IV access and infusion delivery, infection prevention procedures, patient observation protocols, emergency equipment and medicines appropriate to the clinical setting, and a clear escalation plan. For some patients or treatments, a higher-acuity environment or specialist input may be necessary.
Questions patients should ask an IV clinic
A credible clinic should answer straightforward questions clearly. Ask which regulated professional assessed you, who is prescribing the infusion, and whether the treatment is being administered under an individual prescription or a PGD. You can also ask how the clinic checks medical suitability, manages adverse reactions, records treatment, and communicates with your usual healthcare team where appropriate.
Be wary of services that present prescribing as a formality, promise that an infusion is suitable for everyone, or cannot explain who holds clinical responsibility. A consultation that feels rushed or avoids discussion of medicines, health conditions and possible risks is not a reassuring sign.
For clinic operators, transparent answers are not merely good customer service. They demonstrate that prescribing, supply, administration and follow-up have been designed as a safe clinical pathway rather than as separate commercial transactions.
Professional accountability and local governance
The prescriber must work within the standards of their regulator, as well as applicable medicines legislation and local governance arrangements. In England, clinics carrying out regulated activities may also need to meet Care Quality Commission requirements. Requirements can differ across the UK nations, so providers should ensure their registration and governance arrangements reflect where and how they operate.
Policies should cover patient assessment, prescribing, supply, storage, administration, consent, record keeping, incident reporting and emergency response. Clinical oversight should include regular audit, review of adverse events and a process for updating practice when guidance, products or service risks change.
Ultimately, the safest answer to who can prescribe an infusion is not just a job title. It is an appropriately authorised prescriber who has the competence, information and governance support to decide whether that infusion is right for that individual. Patients should expect that standard, and responsible providers should be ready to show how they meet it.